U.S. market Closed. Opens in 15 hours 45 minutes

SILK | Silk Road Medical, Inc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue177.13M138.64M101.47M75.23M63.35M34.56M14.26M
Cost of Revenue50.05M37.88M25.45M21.29M15.93M10.87M5.13M
Gross Profit127.09M100.76M76.03M53.94M47.43M23.68M9.13M
Operating Expenses186.36M152.77M123.50M96.80M75.49M45.08M27.50M
Selling, General & Admin145.03M116.32M96.39M75.52M63.22M34.82M20.26M
Research & Development41.32M36.45M27.11M21.27M12.27M10.26M7.24M
Other Operating Expenses442.00K-190.00K-23.00K-80.00K-21.05M-12.06MN/A
Operating Income-59.27M-52.00M-47.47M-42.86M-28.07M-21.39M-18.37M
Other Expenses / Income3.53M-3.01M-2.34M-4.51M-24.35M-12.06M-982.00K
Before Tax Income-55.74M-55.01M-49.81M-47.37M-52.41M-37.63M-19.36M
Income Tax Expenses43.00K3.01M576.00K3.02M3.66M-11.87MN/A
Net Income-55.74M-58.02M-50.39M-50.38M-56.07M-37.63M-19.36M
Interest Expenses6.87M5.10M2.52M4.41M4.95M4.36M3.94M
Basic Shares Outstanding38.80M35.78M34.64M32.97M22.96M28.71M24.05M
Diluted Shares Outstanding38.80M35.78M34.64M32.97M22.96M28.71M24.05M
EBITDA-55.48M-49.67M-47.29M-41.76M-26.41M-32.75M-15.28M
EBITDA Margin-31.32%-35.82%-46.61%-55.51%-41.68%-94.78%-107.20%
EBIT-48.83M-49.91M-47.29M-42.95M-47.46M-45.14M-15.41M
EBIT Margin-27.57%-36.00%-46.61%-57.10%-74.92%-130.63%-108.10%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙